JP2013544877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544877A5 JP2013544877A5 JP2013542630A JP2013542630A JP2013544877A5 JP 2013544877 A5 JP2013544877 A5 JP 2013544877A5 JP 2013542630 A JP2013542630 A JP 2013542630A JP 2013542630 A JP2013542630 A JP 2013542630A JP 2013544877 A5 JP2013544877 A5 JP 2013544877A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- thiadiazol
- pyridin
- carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC([C+]N=C([C@@]([C@]([C@@](C)C([C@](C)CC(C[C@@](C)C([C@](C)C(OC1)=O)=O)OC)=O)[C@@]1(C)O1)C1=O)N)P* Chemical compound CC([C+]N=C([C@@]([C@]([C@@](C)C([C@](C)CC(C[C@@](C)C([C@](C)C(OC1)=O)=O)OC)=O)[C@@]1(C)O1)C1=O)N)P* 0.000 description 2
- MIZDRGWPIKBPQC-UHFFFAOYSA-N BrCc1nnc(-c2ncccn2)[s]1 Chemical compound BrCc1nnc(-c2ncccn2)[s]1 MIZDRGWPIKBPQC-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3352MU2010 | 2010-12-09 | ||
| IN3352/MUM/2010 | 2010-12-09 | ||
| PCT/IB2011/050464 WO2012076989A1 (en) | 2010-12-09 | 2011-02-03 | Ketolide compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015135252A Division JP6102991B2 (ja) | 2010-12-09 | 2015-07-06 | ケトライド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544877A JP2013544877A (ja) | 2013-12-19 |
| JP2013544877A5 true JP2013544877A5 (enExample) | 2014-03-20 |
| JP5851516B2 JP5851516B2 (ja) | 2016-02-03 |
Family
ID=54259620
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013542630A Expired - Fee Related JP5851516B2 (ja) | 2010-12-09 | 2011-02-03 | ケトライド化合物 |
| JP2015135252A Expired - Fee Related JP6102991B2 (ja) | 2010-12-09 | 2015-07-06 | ケトライド化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015135252A Expired - Fee Related JP6102991B2 (ja) | 2010-12-09 | 2015-07-06 | ケトライド化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9175031B2 (enExample) |
| EP (2) | EP2673285B1 (enExample) |
| JP (2) | JP5851516B2 (enExample) |
| KR (1) | KR101657751B1 (enExample) |
| CN (2) | CN105669803A (enExample) |
| AU (1) | AU2011340204B2 (enExample) |
| BR (1) | BR112013014392B1 (enExample) |
| CA (2) | CA2964104A1 (enExample) |
| DK (1) | DK2673285T3 (enExample) |
| ES (1) | ES2642287T3 (enExample) |
| HU (1) | HUE036658T2 (enExample) |
| MX (1) | MX348084B (enExample) |
| NZ (1) | NZ623574A (enExample) |
| PL (1) | PL2673285T3 (enExample) |
| PT (1) | PT2673285T (enExample) |
| RU (1) | RU2601550C2 (enExample) |
| WO (1) | WO2012076989A1 (enExample) |
| ZA (1) | ZA201304150B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ587490A (en) * | 2010-08-20 | 2013-03-28 | Greentide Ltd | Anti-Microbial Compounds containing compounds with a sugar substituent |
| WO2012127351A1 (en) * | 2011-03-22 | 2012-09-27 | Wockhardt Limited | Process for preparation of ketolide compounds |
| US9346828B2 (en) * | 2013-06-07 | 2016-05-24 | Wisconsin Alumni Research Foundation | Forazolines, compositions thereof and uses thereof |
| MX376585B (es) | 2015-07-27 | 2025-03-07 | Chong Kun Dang Pharmaceutical Corp | Compuestos derivados de sulfamida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6, y la composición farmacéutica que comprende los mismos. |
| ES2935932T3 (es) | 2015-07-27 | 2023-03-13 | Chong Kun Dang Pharmaceutical Corp | Compuestos de derivados de 1,3,4-oxadiazolsulfonamida como inhibidor de histona desacetilasa 6, y la composición farmacéutica que comprende los mismos |
| AU2016299485B2 (en) | 2015-07-27 | 2019-02-07 | Chong Kun Dang Pharmaceutical Corp. | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same |
| AU2016303891B2 (en) | 2015-08-04 | 2019-08-01 | Chong Kun Dang Pharmaceutical Corp. | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
| HUE061967T2 (hu) | 2015-10-12 | 2023-09-28 | Chong Kun Dang Pharmaceutical Corp | Hiszton deacetiláz-6 inhibitor oxadiazol-amin származékok és az azokat tartalmazó gyógyászati készítmény |
| CN108778254B (zh) * | 2016-01-12 | 2020-09-04 | 沃克哈特有限公司 | 药物组合物 |
| WO2017122147A1 (en) * | 2016-01-12 | 2017-07-20 | Wockhardt Limited | Pharmaceutical compositions |
| AU2017206671A1 (en) * | 2016-01-12 | 2018-08-23 | Wockhardt Limited | Pharmaceutical compositions for the treatment of bacterial infections |
| US20210122777A1 (en) * | 2017-03-16 | 2021-04-29 | Wockhardt Limited | A process for preparing ketolide compounds |
| KR102316234B1 (ko) | 2018-07-26 | 2021-10-22 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| PH12021552905A1 (en) | 2019-05-31 | 2022-04-04 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oxadiazole homophthalimide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
| CN114728919A (zh) * | 2019-11-05 | 2022-07-08 | 德米拉公司 | MrgprX2拮抗剂及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2473525A1 (fr) | 1980-01-11 | 1981-07-17 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| US4331803A (en) | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
| YU43006B (en) | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| DE69733723T2 (de) | 1996-09-04 | 2006-04-20 | Abbott Laboratories, Abbott Park | 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung |
| WO1999021870A1 (en) * | 1997-10-29 | 1999-05-06 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a 11, 12-carbamate derivatives |
| HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
| FR2777282B1 (fr) * | 1998-04-08 | 2001-04-20 | Hoechst Marion Roussel Inc | Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments |
| KR100502031B1 (ko) | 2000-08-22 | 2005-07-25 | 바실리어 파마슈티카 아게 | 항균 활성을 갖는 신규한 매크롤라이드 |
| GB0031312D0 (en) | 2000-12-21 | 2001-02-07 | Glaxo Group Ltd | Macrolides |
| CZ20031751A3 (cs) | 2000-12-21 | 2004-03-17 | Glaxo Group Limited | Makrolidy |
| GB0127349D0 (en) | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
| US6995143B2 (en) | 2002-02-28 | 2006-02-07 | Basilea Pharmaceutica Ag | Macrolides with antibacterial activity |
| US6727229B2 (en) | 2002-08-19 | 2004-04-27 | Enanta Pharmaceuticals, Inc. | 11,12-substituted lactone ketolide derivatives having antibacterial activity |
| WO2004108744A2 (en) * | 2003-05-19 | 2004-12-16 | Prasad K Deshpande | Azalides and azaketolides having antimicrobial activity |
| JP2008508322A (ja) * | 2004-07-28 | 2008-03-21 | ランバクシー ラボラトリーズ リミテッド | 抗菌剤としてのケトライド誘導体 |
| KR20090042971A (ko) * | 2006-08-24 | 2009-05-04 | 욱크하르트 리서치 센터 | 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드 |
| WO2009075923A2 (en) * | 2007-09-17 | 2009-06-18 | Enanta Pharmaceuticals, Inc. | 6, 11-bridged biaryl macrolides |
| US8552162B2 (en) * | 2008-05-09 | 2013-10-08 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives |
| NZ596628A (en) * | 2009-05-27 | 2013-03-28 | Ketolide compounds having antimicrobial activity |
-
2011
- 2011-02-03 JP JP2013542630A patent/JP5851516B2/ja not_active Expired - Fee Related
- 2011-02-03 CN CN201610004950.0A patent/CN105669803A/zh active Pending
- 2011-02-03 AU AU2011340204A patent/AU2011340204B2/en not_active Ceased
- 2011-02-03 EP EP11708092.9A patent/EP2673285B1/en active Active
- 2011-02-03 NZ NZ623574A patent/NZ623574A/en not_active IP Right Cessation
- 2011-02-03 CA CA2964104A patent/CA2964104A1/en not_active Abandoned
- 2011-02-03 DK DK11708092.9T patent/DK2673285T3/en active
- 2011-02-03 PL PL11708092T patent/PL2673285T3/pl unknown
- 2011-02-03 RU RU2013131234/04A patent/RU2601550C2/ru active
- 2011-02-03 BR BR112013014392-4A patent/BR112013014392B1/pt active IP Right Grant
- 2011-02-03 ES ES11708092.9T patent/ES2642287T3/es active Active
- 2011-02-03 EP EP17164547.6A patent/EP3216798A3/en not_active Withdrawn
- 2011-02-03 PT PT117080929T patent/PT2673285T/pt unknown
- 2011-02-03 HU HUE11708092A patent/HUE036658T2/hu unknown
- 2011-02-03 US US13/991,762 patent/US9175031B2/en active Active
- 2011-02-03 MX MX2013006461A patent/MX348084B/es active IP Right Grant
- 2011-02-03 KR KR1020137016527A patent/KR101657751B1/ko not_active Expired - Fee Related
- 2011-02-03 CA CA2820451A patent/CA2820451C/en not_active Expired - Fee Related
- 2011-02-03 WO PCT/IB2011/050464 patent/WO2012076989A1/en not_active Ceased
- 2011-02-03 CN CN201180066627.1A patent/CN103384676B/zh active Active
-
2013
- 2013-06-06 ZA ZA2013/04150A patent/ZA201304150B/en unknown
-
2015
- 2015-07-06 JP JP2015135252A patent/JP6102991B2/ja not_active Expired - Fee Related
- 2015-09-19 US US14/859,254 patent/US20160083412A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544877A5 (enExample) | ||
| RU2013131234A (ru) | Кетолидные соединения | |
| US9926285B2 (en) | Allosteric modulators of nicotinic acetylcholine receptors | |
| JP5728487B2 (ja) | 三環式ヘテロ環化合物 | |
| US10047083B2 (en) | Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
| UA122385C2 (uk) | Сульфамоїлариламіди та їх застосування як лікарських препаратів для лікування гепатиту b | |
| US20230382889A1 (en) | Compounds for inhibiting kif18a | |
| US7432293B2 (en) | Heterocyclic compounds useful as Nurr-1 activators | |
| JP2014532626A5 (enExample) | ||
| JP2010523643A5 (enExample) | ||
| EP1446403B1 (en) | Aryl substituted oxazolidinones with antibacterial activity | |
| JP2003515607A (ja) | 置換イソオキサゾリン類及びその抗菌剤としての使用 | |
| JPWO2013018735A1 (ja) | アミジン化合物又はその塩 | |
| CN102639513A (zh) | 鞘氨醇激酶抑制剂 | |
| US20180127407A1 (en) | Benzothiazole Or Benzoxazole Compounds As Sumo Activators | |
| JP2017511368A5 (enExample) | ||
| US7326790B2 (en) | Diphenylisoxazole compounds and hydro isomers thereof | |
| KR20040086465A (ko) | 화합물 | |
| CN101142183A (zh) | 有丝分裂驱动蛋白抑制剂 | |
| CN107540624B (zh) | 热休克蛋白抑制剂及其制备方法和应用 | |
| KR101169359B1 (ko) | 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 | |
| RU2006140998A (ru) | Производные пиридоиндолона, замещенные в положении 6, их получение и применение в терапии | |
| JP2017165653A (ja) | アゾールカルボン酸誘導体 | |
| JP2014074018A5 (enExample) | ||
| US20120101124A1 (en) | 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists |